A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients

Craig S. Sauter, Juliet N. Barker, Lauren Lechner, Junting Zheng, Sean M. Devlin, Esperanza B. Papadopoulos, Miguel Angel Perales, Ann A. Jakubowski, Jenna D. Goldberg, Guenther Koehne, Izaskun Ceberio, Sergio Giralt, Andrew D. Zelenetz, Craig H. Moskowitz, Hugo Castro-Malaspina

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint Dive into the research topics of 'A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences